Table 1.
Pomegranate's molecular targets in malignancies.
| Cancers | Cellular Targets | In vitro/in vivo/clinical | Extract/Phytochemical | Mechanism | References |
|---|---|---|---|---|---|
| Skin | MAPK activation (UVB-mediated), STAT3, and NFκB signaling pathway inhibition | In vitro, in vivo | Galactomannan (PSP001) isolated from the fruit rind, Fruit extract | Down-regulation of VEGF & MMPs | [[17], [18], [19], [20], [21]] |
| Breast | Anti-estrogenic and anti-aromatase properties are shown by this compound | In vitro | Extract (peel) | Decreased expression of β-catenin & EMT markers | [22,23] |
| Estrogen-responsive genes inhibition | In vitro | Extract (peel oil) | Down-regulation of metastasis-related genes | [24,25] | |
| Pro-inflammatory cytokines, as well as chemokines and vascular endothelial growth factors, are reduced | In vitro | Extract (seed) | Reduced secretion of inflammatory cytokines | [[26], [27], [28], [29], [30]] | |
| Prostate | Reduce the serum PSA ranges | In vitro, in vivo | Fruit extract | NF-κB blockade | [31,32] |
| NF-κB activation and STAT3 phosphorylation is regulated and reduced | In vitro, in vivo | Fruit extract | Decreased expression of HIF-1α &VEGF | [[32], [33], [34], [35]] | |
| IGF-1/Akt/mTOR signaling inhibition | in vivo | Luteolin Ellagic acid + Punicic acid | Decreased expression of oncogenic miRNAs & inhibition of the CXCR4/SDF1α chemotaxis axis, changes in the expression of cell adhesion & cytoskeletal proteins | [[36], [37], [38]] | |
| Lung | Reduce p27 and p21 protein transformation PCNA, Ki-67, and cyclins/CDKs transformation downregulation PI3K/Akt, MAPK, and NF-κB signaling pathways inhibition |
In vitro | Extract (leaves) | Reduction of MMP-2 & MMP-9 expression | [39,40] |
| It prevents the production of DNA adducts. | In vitro | Galactomannan (PSP001) isolated from the fruit rind | Down-regulation of VEGF & MMPs | [21,41,42] | |
| Proliferative, inflammation, and angiogenesis-related indicators are all reduced. c-Met and MAPK phosphorylation prevention | In vivo | Fruit extract | Information not available | [43,44] | |
| Colon | Cyclooxygenase-2 transformation, the binding activity of NFκB DNA, and Akt phosphorylation prevention | In vitro, In vivo | Juice | Targeting miR-126-regulated pathways which contribute in anti-inflammatory & anti-angiogenic mechanisms | [42,45] |
| Hepatic GST action is reduced | In vitro, in vivo | Juice, Tannin, Punicalagin | Abolish TNFα-induced AKT activation resulting modulation of inflammatory cell signaling | [46,47] | |
| miR-18a-3p, miR-181c-3p, miR-1249, miR-765, miR-646, miR-496 modulation | Information not available | Information not available | Information not available | [48] |
MAPK: Mitogen-activated protein kinase; GST: Glutathione-S-transferase; TNFα: tumor necrosis factor alpha; VEGF: Vascular endothelial growth factor; MMPs: Matrix metalloproteinases; HIF-1α: Hypoxia-inducible factor 1-alpha; PSA: Prostate-specific antigen; IGF-1: insulin-like growth factor 1; PCNA: Proliferating cell nuclear antigen; CDKs: Cyclin-dependent kinases; DNA: Deoxyribonucleic acid.